SCHEMBL6730073

SCHEMBL6730073

C/C=C\C=C(/C=C/C)C(=O)N(Cc1cccc(-c2ccc3[nH]ccc3c2)c1)C1CCN(C)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 1/20 0.34
▸ SLC6A2 P23975 5/20 0.34
▸ SLC6A4 P31645 5/20 0.34
▸ SLC6A3 Q01959 5/20 0.34
▸ PRKACA P17612 3/20 0.34
▸ PRKACG P22612 3/20 0.34
▸ PRKACB P22694 3/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ PRKCZ Q05513 1/20 0.34
▸ WDR5 P61964 1/20 0.34
▸ F2 P00734 1/20 0.34
▸ F10 P00742 1/20 0.34
▸ PLG P00747 1/20 0.34
▸ PLAU P00749 1/20 0.34
▸ ST14 Q9Y5Y6 1/20 0.34
▸ CDK8 P49336 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ ENPP2 Q13822 1/20 0.33
▸ FASN P49327 1/20 0.33
▸ MAP3K11 Q16584 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6729868 0.79 FASN (0.36) SLC6A2SLC6A4SLC6A3FASN
SCHEMBL13604748 0.78 OPRM1 (0.51) F2F10PLGPLAUST14
SCHEMBL3692393 0.78 TP53 (0.43) MAP4K4MAP3K11
SCHEMBL3698984 0.78 OPRM1 (0.48) SLC6A2SLC6A4SLC6A3FASN
SCHEMBL3693392 0.76 OPRM1 (0.43) WDR5F2F10PLGPLAU
SCHEMBL3695933 0.76 CACNA2D1 (0.38) AOC3SLC6A2SLC6A4SLC6A3PRKACA
SCHEMBL27711121 0.75 DYRK1A (0.42) CDK8MAP4K4MAP3K11
SCHEMBL27731712 0.69 WDR5 (0.47) WDR5
SCHEMBL3697284 0.68 MAPK14 (0.55) PRKACAPRKACGPRKACBCDK2MAP3K11
SCHEMBL3705209 0.68 MAP4K4 (0.52) PRKACAPRKACGPRKACBCDK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851199-B1 SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS AVENTIS PHARMA INC (US) 2012-05-16 — — EP disclosed
Send feedback